about
An international registry for women exposed to Zika virus during pregnancy: time for answers.Emerging Role of Zika Virus in Adverse Fetal and Neonatal OutcomesHarness shared data in international Zika registryUtility of an Algorithm to Increase the Accuracy of Medication History in an Obstetrical SettingZika virus: are we going too far?Medication use in pregnancy: a cross-sectional, multinational web-based studyRisk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.Use of atypical antipsychotics in pregnancy and maternal gestational diabetes.Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients.Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.Pregnancy outcome following maternal exposure to pregabalin may call for concern.Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure.Pregabalin use early in pregnancy and the risk of major congenital malformations.Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study.Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry.Clinical management of pregnant women exposed to Zika virus.Clinical management of pregnant women exposed to Zika virus.Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis.Outbreak in meldonium positive laboratory tests: are we missing something?Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report.Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry.Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometry.Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.Zika virus, vaccines and antiviral strategies.Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale.Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique[SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio]Antiepileptika bei Frauen im gebärfähigen Alter und in der SchwangerschaftRisk perception by healthcare professionals related to drug use during pregnancy: a Swiss surveyPregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospective StudyPreliminary results of venlafaxine exposure in pregnancy, a multicenter prospective cohort ENTIS studyManagement of Deficient Lactation in Switzerland and Canada: A Survey of Midwives' Current Practices[Drugs and breastfeeding: some facts to consider before deciding they are incompatible]
P50
Q26271252-D569DA8A-775F-405A-BF25-F6FD7089E278Q27010776-9765532D-D0E8-46D8-903B-ECDF2A1CB6DEQ27134392-751AF7BA-874B-4754-9D39-BA8AB33ED3F5Q28550918-0C8CBF50-4E3B-4B46-A8F3-1372F96EECC9Q28595384-C69D63F0-6F30-4668-A7A8-B0A0246FBEA8Q30572132-F371727F-2B94-4D78-9FB3-E7C275927AF1Q38305749-F4ED2BB0-730F-4A15-A6EC-0B819B11F12AQ38372168-F5FB1ACF-C0A8-4407-A652-387918FBD9D3Q38760587-DA263D91-42D1-4F3A-AC37-8B79C522DFEDQ39474187-9FB80B22-D742-4E08-8633-86E447FB8F13Q39754837-148026B5-202D-41BC-8AC4-21B16123FA15Q39756442-943D3686-1002-44EC-8DA6-67CED0B7CC34Q40226298-C204C28E-2C1B-4E76-A693-89C67C363F98Q40735151-976E3FE6-4D7C-4353-B25F-87CA7A3C9A1DQ41129361-B6C15EFC-1E05-40A7-8AFD-1C94B98A8A09Q41374090-F1999119-BCE2-41B8-AB79-3A00B0BA888CQ42205826-A23AC6C0-F842-457E-B25A-BB2A5AEFA9BDQ42990394-257C2B9B-9DA4-4E52-BBD3-0AA9E0C809FBQ43026544-3A6832A7-987D-4DC5-B877-2B5AF5315E75Q43233510-5938DBF4-07E6-40A7-A8BF-DE905A7469EAQ43756820-80BA8700-A552-4C95-8E86-9E387BE7364AQ44068752-20454403-1E05-4306-8E02-0E6E60936B32Q46669704-50EF39F0-8812-4754-B56B-26DBC5FC502EQ46834296-383CA44A-0850-48A7-9065-8E2D3C005386Q47583728-3095155F-4E8C-496D-84D4-D5447D17373BQ47835751-2BC122DD-B61D-494E-89E8-8BBF1795AB8FQ48565050-C1869A80-D845-496D-9BD7-63558BB03ADBQ48649257-B516121C-8879-47E8-913F-B7B9E4ED7644Q48798365-6F7D8F6F-8B5F-42DD-84EC-D832FC3C58BAQ52885913-1BD68802-9F02-4504-8948-64C5633D5FCEQ55084364-D463F89C-2041-482D-BA87-815E626A1010Q55184960-CDF3AAB9-0BB7-4799-9299-109A4C67712EQ56379721-262189A5-ABE0-428D-A71A-40B1E4F0308EQ56423126-6F083443-A484-4840-9239-DCD9FB8104C8Q56423205-6F6D5976-A28C-4EE1-AB70-0836D079F7F2Q56423221-B8B7139C-F98C-4ADF-BC55-EC1718D7A44EQ56423258-2D231F45-9212-4F45-B712-72E9F2CAE6B6Q56423295-E23EB986-DC25-4CD8-B972-42DDF25D3EC3Q56423303-B520BBE0-FA38-4026-84BF-44FA52BF91ABQ56423349-BF7F7FCA-7BB1-4687-AB5A-EFF9018CD400
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alice Panchaud
@ast
Alice Panchaud
@en
Alice Panchaud
@es
Alice Panchaud
@nl
type
label
Alice Panchaud
@ast
Alice Panchaud
@en
Alice Panchaud
@es
Alice Panchaud
@nl
altLabel
alice panchaud
@en
prefLabel
Alice Panchaud
@ast
Alice Panchaud
@en
Alice Panchaud
@es
Alice Panchaud
@nl
P106
P21
P31
P3835
alice-panchaud
P496
0000-0001-6086-2401